Samuels-Lev Y, O'Connor D J, Bergamaschi D, Trigiante G, Hsieh J K, Zhong S, Campargue I, Naumovski L, Crook T, Lu X
Ludwig Institute for Cancer Research, Imperial College School of Medicine, St. Mary's Campus, Norfolk Place, London W2 1PG, United Kingdom.
Mol Cell. 2001 Oct;8(4):781-94. doi: 10.1016/s1097-2765(01)00367-7.
We identified a family of proteins termed ASPP. ASPP1 is a protein homologous to 53BP2, the C-terminal half of ASPP2. ASPP proteins interact with p53 and specifically enhance p53-induced apoptosis but not cell cycle arrest. Inhibition of endogenous ASPP function suppresses the apoptotic function of endogenous p53 in response to apoptotic stimuli. ASPP enhance the DNA binding and transactivation function of p53 on the promoters of proapoptotic genes in vivo. Two tumor-derived p53 mutants with reduced apoptotic function were defective in cooperating with ASPP in apoptosis induction. The expression of ASPP is frequently downregulated in human breast carcinomas expressing wild-type p53 but not mutant p53. Therefore, ASPP regulate the tumor suppression function of p53 in vivo.
我们鉴定出了一个名为ASPP的蛋白质家族。ASPP1是一种与53BP2同源的蛋白质,ASPP2的C端一半。ASPP蛋白与p53相互作用,特异性增强p53诱导的凋亡,但不影响细胞周期停滞。抑制内源性ASPP功能可抑制内源性p53在凋亡刺激下的凋亡功能。在体内,ASPP增强p53对促凋亡基因启动子的DNA结合和反式激活功能。两个凋亡功能降低的肿瘤来源的p53突变体在诱导凋亡时与ASPP协同作用存在缺陷。在表达野生型p53而非突变型p53的人乳腺癌中,ASPP的表达经常下调。因此,ASPP在体内调节p53的肿瘤抑制功能。